Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM-111 in Acute Sensorineural Hearing Loss
NCT00802425Phase 2Completed
- Sponsor
- Altamira Therapeutics
- Start
- Dec 2008
- Primary completion
- Jul 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of brimapitide in acute sensorineural hearing loss, sponsored by Altamira Therapeutics. Started Dec 2008; status: completed.
02
Drugs
brimapitide
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on NCT00802425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802425.